Etoposide and Red cell distribution width increased - a phase IV clinical study of FDA data
Summary:
Red cell distribution width increased is reported as a side effect among people who take Etoposide (etoposide), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Ifosfamide, and have Non-hodgkin's lymphoma.
The phase IV clinical study analyzes which people have Red cell distribution width increased when taking Etoposide. It is created by eHealthMe based on reports of 77,756 people who have side effects when taking Etoposide from the FDA, and is updated regularly.
What is Etoposide?
Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.
What is Red cell distribution width increased?
Red cell distribution width increased is found to be associated with 604 drugs and 656 conditions by eHealthMe. Check the latest studies of Red cell distribution width increased.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
77,756 people reported to have side effects when taking Etoposide.
Among them, 24 people (0.03%) have Red cell distribution width increased.

Among these 24 people:
How long have people been on Etoposide when they have Red cell distribution width increased? *
- < 1 month: 54.55 %
- 1 - 6 months: 45.45 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Red cell distribution width increased when taking Etoposide? *
- female: 15.79 %
- male: 84.21 %
What is the age of people who have Red cell distribution width increased when taking Etoposide? *
- 0-1: 0.0 %
- 2-9: 10.53 %
- 10-19: 0.0 %
- 20-29: 5.26 %
- 30-39: 0.0 %
- 40-49: 36.84 %
- 50-59: 26.32 %
- 60+: 21.05 %
What are other drugs people take besides Etoposide? *
- Ifosfamide: 15 people, 62.50%
- Carboplatin: 14 people, 58.33%
- Cisplatin: 11 people, 45.83%
- Cyclophosphamide: 11 people, 45.83%
- Cytarabine: 10 people, 41.67%
- Bendamustine: 10 people, 41.67%
- Gemcitabine: 10 people, 41.67%
- Dexamethasone: 9 people, 37.50%
- Methylprednisolone: 9 people, 37.50%
- Oxaliplatin: 9 people, 37.50%
What are other side effects people have besides Red cell distribution width increased? *
- Haemoglobin Decreased: 19 people, 79.17%
- Blood Lactate Dehydrogenase Increased: 14 people, 58.33%
- Monocyte Count Increased: 11 people, 45.83%
- Disease Progression: 11 people, 45.83%
- Red Blood Cell Count Decreased: 11 people, 45.83%
- White Blood Cell Count Decreased: 10 people, 41.67%
- Haematocrit Decreased: 10 people, 41.67%
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 9 people, 37.50%
- C-Reactive Protein Increased: 9 people, 37.50%
- Lymphadenitis (inflammation or enlargement of a lymph node): 8 people, 33.33%
What are the existing conditions these people have? *
- Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 16.67%
- Small Cell Lung Cancer Stage Unspecified (lung cancer in unknown stage): 3 people, 12.50%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 8.33%
- Stress And Anxiety: 1 person, 4.17%
- Osteosarcoma Metastatic (a cancerous (malignant) bone tumour can spreads to other parts): 1 person, 4.17%
- Non-Small Cell Lung Cancer Stage Iii: 1 person, 4.17%
- Neuroblastoma Recurrent (reoccurrence of a cancer that forms in your nerve tissue): 1 person, 4.17%
- Nausea (feeling of having an urge to vomit): 1 person, 4.17%
- Metastases To Lung (cancer spreads to lung): 1 person, 4.17%
- Lymphoma Transformation (change in the nature of blood cell cancer): 1 person, 4.17%
* Approximation only. Some reports may have incomplete information.
Do you take Etoposide and have Red cell distribution width increased?
- Check whether Red cell distribution width increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Etoposide:
- Etoposide (77,815 reports)
Red cell distribution width increased treatments and more:
- Red cell distribution width increased (5,525 reports)
How severe was Red cell distribution width increased and when was it recovered:
Expand to all the drugs that have ingredients of etoposide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Etoposide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Red cell distribution width increased:
- Red cell distribution width increased (604 drugs)
Browse all the conditions that are associated with Red cell distribution width increased:
- Red cell distribution width increased (656 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on etoposide (the active ingredients of Etoposide) and Etoposide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lokelma cause Dyspnea Exacerbated? - 26 seconds ago
- Could Mirtazapine cause Dyspnea Exacerbated? - 39 seconds ago
- Alavert vs. Nasonex, side effect and effectiveness comparison - 54 seconds ago
- Osteoporosis and Gastric Dilatation - 56 seconds ago
- Entresto and Sinus Tachycardia for Men aged 60+ - a minute ago
- Furosemide and Muscle Spasm for Men aged 30-39 - a minute ago
- Furosemide and Muscle Spasms for Men aged 30-39 - a minute ago
- Trimox and Duragesic drug interactions for women aged 60+ - a minute ago
- Could Flutamide cause Fall? - a minute ago
- Skyla vs. Femcon Fe, side effect and effectiveness comparison - a minute ago